Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Therefore, if a new oral drug in development is intended to be co-administered with a GLP-1 agonist, we highly recommend conducting a healthy volunteer drug-drug interaction prior to Phase 3 trials to characterize the impact on the PK of the candidate new drug
Collins, L., & Costello, R
Advancing GLP-1 therapeutics with analytical innovation The development of GLP-1-based drugs, which are used to treat type 2 diabetes and obesity, requires precise, high-sensitivity analytical techniques to navigate the complexity of peptide therapeutics
Inflammopharmacol 31:943965
US$ 25.08
US$ 22.07
US$ 22.54
US$ 28.23
US$ 22.57
